Back to News
Market Impact: 0.05
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Source: globenewswire.com
Healthcare & BiotechManagement & Governance
CRISPR Therapeutics announced that senior management will present at Morgan Stanley's 24th Annual Global Healthcare Conference on September 14, 2026 at 1:05 p.m. The announcement contains no financial results, clinical updates, guidance, or other material business developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
CRSP0.10
MS0.00
More News
- Lilly perseveres in a bad day for drug stocks — plus, Boeing's mixed deliveries
- Dell’s latest reinvention is here — and it reveals the AI boom happening ‘on-premise.’ The markets missed it
- Why CRISPR Therapeutics Stock Rocked the Market Last Month
- Stocks making the biggest moves midday: Amgen, Qualcomm, Expedia, CoreWeave & more
- Stocks making the biggest moves premarket: Peloton Interactive, Roivant Sciences, Boston Scientific & more
- Here are Tuesday's biggest analyst calls: Nvidia, SpaceX, Apple, Intel, Airbnb, Lockheed Martin, Tesla & more